Age-related macular degeneration (AMD) remains a leading cause of vision loss, but new therapies are reshaping its treatment.

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced it has received a patent (US Patent No. 12,364,680) covering KIO-104 for the treatment of a wide range of ocular diseases. This includes, but ...

List today: Belite Bio BLTE is a clinical stage biopharmaceutical drug development company which focused on novel ...

This systematic review comprehensively summarizes treatment approaches for all types of age-related macular degeneration (AMD ...

Today on Hustling Sideways, we talk to Dr. Roger Wu, an optometrist looking to change eyecare with The Eye Drink.

The conference highlighted the latest in scientific advances in treatments for the most common eye diseases, including age-related macular degeneration, diabetic macular edema, and diabetic ...

Age-related macular degeneration (AMD) remains a leading cause of vision loss globally, with significant advancements in ...

A new study examining age-related macular degeneration (AMD) among elderly residents in Egyptian geriatric homes revealed connections between this vision condition and dangerous falls.

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.

Whether you’re a latte lover, a mocha monster or an espresso elitist — people have strong preferences when it comes to coffee ...

Age-related macular degeneration is a leading cause of blindness and affects over 196 million people worldwide. Despite its prevalence, very little is known about the causes or mechanisms of this ...